The global Lennox Gastaut Syndrome Market is projected to experience substantial revenue growth, primarily driven by the increasing prevalence of epilepsy. According to the World Health Organization (WHO), epilepsy accounts for more than 0.5% of the disease burden, and Lennox-Gastaut Syndrome is more commonly observed in males than females. The National Organization for Rare Diseases estimates that Lennox-Gastaut Syndrome causes 1%-4% of all cases of infantile epilepsy, affecting approximately 0.1-0.28 individuals per 100,000 people.
https://www.reportsanddata.com..../report-detail/lenno
Like
Comment
Share
